68 Ga-FAPI-04: A Powerful Tool for Detecting Subcentimeter Metastases of Intrahepatic Cholangiocarcinoma

  • 0Department of Nuclear Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.

|

|

Summary

This summary is machine-generated.

Gallium-68 FAPI PET/CT imaging offers superior detection of small intrahepatic cholangiocarcinoma metastases compared to standard FDG PET/CT and MRI. This advanced imaging technique improves the identification of recurrent disease, aiding in patient management.

Area Of Science

  • Oncology
  • Nuclear Medicine
  • Radiology

Background

  • Intrahepatic cholangiocarcinoma (ICC) is a rare but aggressive biliary tract cancer.
  • Recurrence, particularly with small subcentimeter liver metastases, poses a diagnostic challenge.
  • Current imaging modalities may have limitations in detecting minimal residual disease.

Purpose Of The Study

  • To evaluate the diagnostic performance of 68Ga-FAPI-04 PET/CT in detecting subcentimeter liver metastases from intrahepatic cholangiocarcinoma.
  • To compare the sensitivity of 68Ga-FAPI-04 PET/CT with 18F-FDG PET/CT and conventional MRI.

Main Methods

  • A case study involving a 53-year-old woman with a history of resected ICC.
  • Comparison of imaging findings from 18F-FDG PET/CT, 68Ga-FAPI-04 PET/CT, and contrast-enhanced MRI.
  • Assessment of lesion detection rates and tracer uptake in identified metastases.

Main Results

  • 18F-FDG PET/CT failed to detect any FDG-avid lesions.
  • 68Ga-FAPI-04 PET/CT successfully identified three subcentimeter liver metastases with high FAPI uptake.
  • Conventional and contrast-enhanced MRI detected only 1-2 lesions, missing at least one metastasis identified by 68Ga-FAPI-04 PET/CT.

Conclusions

  • 68Ga-FAPI-04 PET/CT demonstrates superior sensitivity for detecting small, subcentimeter liver metastases of intrahepatic cholangiocarcinoma.
  • Fibroblast Activation Protein (FAP) targeted imaging offers a significant advantage over 18F-FDG PET/CT and MRI in this clinical scenario.
  • 68Ga-FAPI-04 PET/CT may improve the early detection and management of recurrent ICC.